Favourites   Have ideas?  Sign in / Register

Positive:   Disease: Acute ischemic stroke (AIS) ↓18.82   Biopharma ↓18.82   Pharmaceutical  ↓8.2 «See more»   Dermatology ↓0.64   Country: Greate Britain ↑15.32   Artificial Intelligence ↑15.32


Disease: Kidney segment

AKBA Akebia Therapeutics, Inc. - Common Stock 0 + Medicine, Disease: Kidney

Last highlighted: #AKBA SEC report: Akebia Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Akebia Therapeutics, Inc. -- SEC File Number 211148438
+ My List
CARA Cara Therapeutics, Inc. - Common Stock -0.64% -0.64% 0 + Medicine, Disease: Kidney, Disease: Liver, Skin, Dermatology

Last highlighted: Form 8-K: Regulation FD Disclosure. On April 29, 2021, Cara Therapeutics issued a press release announcing topline.. $CARA https://t.co/cUtiqqrXat
+ My List
DMAC DiaMedica Therapeutics Inc. - Common Stock -18.82% -18.82% 0 + Biopharma, Disease: Kidney, Medicine, Disease: Acute ischemic stroke (AIS)

+ My List
RETA Reata Pharmaceuticals, Inc. - Class A Common Stock -8.2% -8.2% 0 + Pharmaceutical , Disease: Kidney, Medicine

+ My List
RNLX Renalytix AI plc - American Depositary Shares 15.32% 15.32% 0 + Country: Greate Britain, Medicine, Disease: Kidney, Artificial Intelligence

Last highlighted: $RNLX 6-K Renalytix AI (2 Mar, 6:10am) 📰 RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021 https://t.co/XIBCrGVTeh #RNLX #6K #RenalytixAI #News
+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.